Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390260
Status:
COMPLETED
Last Update Posted:
2017-02-02
First Post:
2006-10-18
Brief Title:
Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery 0966-179COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
Randomized Double-Blind Placebo-Controlled Trial of the Effect of Rofecoxib 50 mg and Hydrocodone 75 mg With Acetaminophen 750 mg in Patients With Postoperative Arthroscopic Pain
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study the effect of rofecoxib 50 mg compared to both placebo and hydrocodone 75 mg with acetaminophen 750 mg to treat moderate to severe pain following arthroscopic knee surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_535 | None | None | None |